Navigation Links
WHO Urges Shah Rukh Khan to Stop Endorsing Tobacco Products

A senior official of the World Health Organisation (WHO) Wednesday termed as "horrible" endorsement of tobacco products by Shah Rukh Khan and motor racing// legend Michael Schumacher and urged them to stop promoting what was a "social malice".

"We know that celebrities in both Hollywood and Bollywood are endorsing tobacco in a huge way and we denounce it vehemently. It's really horrible to see public faces not showing enough responsibility," said Robert Beaglehole, director of the chronic diseases and health promotion at the WHO, in an interview to IANS.

He said players like Michael Schumacher or some Indian film stars should not associate themselves with tobacco products. "They have a huge fan following and promoting such products is nothing but a social malice."

Referring to Shah Rukh Khan's reported remarks that the government should rather ban the manufacturing of tobacco products instead of banning smoking on screen or endorsing such products, the WHO official said: "It is utter irresponsibility."

"We are in touch with many countries and have urged the governments including in India to discourage such practices. WHO knows that the Indian government is trying to curb these practices but what we expect is an equal responsibility on the part of celebrities," Beaglehole said on the sidelines of the Global Youth Meet on Health in this city of the Taj Mahal.

With a huge population of cinema and sports buffs in India, the celebrities should come out of a profit-making mentality, Beaglehole said, adding: "Celebrities in the fields of music, film and sports should not do anything that influences the public behaviour negatively."

He said New Zealand had already banned celebrities from endorsing tobacco products and "it should be considered as a case in point for other countries".

"The Indian government should persuade popular sports and film personalities to endorse the cause of health,
'"/>




Page: 1 2

Related medicine news :

1. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
2. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
3. Minister of State For Industry Urges Corporate Sectors to help India’s Disabled Populatio
4. Lancet Urges To Allow Emergency Contraception Drug As An OTC
5. Ramadoss Urges Celebrities to Stay Away From Soft Drink Ads
6. Ramadoss Urges Celebrities Not To Endorse Soft Drinks
7. Make Medicines Affordable: Jamir Urges Pharma Companies
8. Disabled Girl Urges Kalam to Intervene Against the Denial of Admission
9. Keep Australias GP Workforce Numbers Healthy, AMA Urges
10. AMA Urges Doctors to be Upfront about Fees
11. AAP Urges Families To Create Emergency Disaster Plans
Post Your Comments:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 1Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 2Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 3Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 4Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 1Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 2Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 3Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 4Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 6Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 7Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 8Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 9Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 10Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 11Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 12Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 13Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 14Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 15Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 16Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 17Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 18Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 19Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 20Geneticists hunt for scleroderma triggers 60340 1Geneticists hunt for scleroderma triggers 60340 2